Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.180
+0.010 (0.85%)
At close: Oct 2, 2026, 4:00 PM EDT
1.260
+0.080 (6.78%)
After-hours: Oct 2, 2026, 7:36 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $81.15 million as of October 2, 2026. Its market cap has increased by 72.58% in one year.
Market Cap
81.15M
Enterprise Value
76.12M
1-Year Change
72.58%
Ranking
Category
Stock Price
$1.18
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $81.15M, a decrease of -60.85%. That is a compound annual growth rate of -29.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 81.15M | 77.48% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 87.97M |
| MediciNova | 87.61M |
| Conexeu Sciences | 87.44M |
| Cardiff Oncology | 87.13M |
| Acrivon Therapeutics | 85.28M |
| ProMIS Neurosciences | 84.30M |
| Oncolytics Biotech | 80.46M |
| Pelthos Therapeutics | 78.87M |